Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sobi
Pharma
Novartis, Apellis roll out rival datasets in rare kidney disease
Novartis and Apellis revealed detailed data on iptacopan and pegcetacoplan this weekend as they race for the prize in a type of rare kidney disease.
Fraiser Kansteiner
Oct 28, 2024 10:03am
Watch out, Novartis. Apellis scores major win in kidney diseases
Aug 8, 2024 2:28pm
Sobi boosts hematology sales with growth across key brands
Jul 16, 2024 1:27pm
Apellis scraps pegcetacoplan development in ALS after trial flop
May 25, 2023 10:37am
In $1.7B buy, Sobi acquires CTI and myelofibrosis drug Vonjo
May 10, 2023 11:25am
RSV antibody deal revamped among AZ, Sanofi and Sobi
Apr 10, 2023 11:29am
